AskAt Inc. announced that the company received an allowance for 5-HT4 receptor agonist use patent in Japan (Application Number: 2012-536636). This use patent allowance grants AskAt the right to develop 5-HT4 receptor agonist (AAT-009) to be used as a drug for Dementia.